C14orf1_0610007P14Rik Activators
C14orf1_0610007P14Rik Activators encompass a variety of chemical compounds that augment the functional activity of C14orf1_0610007P14Rik through their influence on diverse cellular signaling pathways. Compounds like Forskolin and IBMX, which elevate intracellular cAMP levels, could indirectly modulate signaling pathways and cellular processes in which C14orf1_0610007P14Rik is involved. Similarly, kinase inhibitors such as Rapamycin (mTOR inhibitor), LY294002 (PI3K inhibitor), U0126 and PD98059 (MEK inhibitors), and SB203580 (p38 MAPK inhibitor) could impact various signaling cascades, affecting the functional role of C14orf1_0610007P14Rik in these pathways.
Moreover, Staurosporine and SP600125, which target broad-spectrum kinases and JNK, respectively, along with calcium signaling modulators like W7 Hydrochloride, BAPTA-AM, and 2-APB, may also influence the functional activity of C14orf1_0610007P14Rik.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX raises intracellular cAMP levels, possibly affecting pathways related to C14orf1_0610007P14Rik's function. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W7 Hydrochloride, a calmodulin antagonist, might influence calcium signaling pathways linked to C14orf1_0610007P14Rik. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM, a calcium chelator, could impact calcium-dependent pathways associated with C14orf1_0610007P14Rik. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB, a modulator of IP3 receptors and TRP channels, may influence calcium signaling pathways relevant to C14orf1_0610007P14Rik. | ||||||